Crs: Cytokine Release Syndrome () and Carpenter Technology Update
Aptevo Therapeutics has reported promising results in treating AML without CRS, while Carpenter Technology shows strong stock performance.
Aptevo Therapeutics has reported promising results in treating AML without CRS, while Carpenter Technology shows strong stock performance.
